104 related articles for article (PubMed ID: 29155138)
21. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of].
Liao SJ; Deng DR; Xia X
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3080-4. PubMed ID: 19192411
[TBL] [Abstract][Full Text] [Related]
22. C33-A cells transfected with E6*I or E6*II the short forms of HPV-16 E6, displayed opposite effects on cisplatin-induced apoptosis.
Vaisman CE; Del Moral-Hernandez O; Moreno-Campuzano S; Aréchaga-Ocampo E; Bonilla-Moreno R; Garcia-Aguiar I; Cedillo-Barron L; Berumen J; Nava P; Villegas-Sepúlveda N
Virus Res; 2018 Mar; 247():94-101. PubMed ID: 29452161
[TBL] [Abstract][Full Text] [Related]
23. Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
Wu C; Kajitani N; Schwartz S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208770
[TBL] [Abstract][Full Text] [Related]
24. [Prokaryotic expression and identification of human papillomavirus type 16 E5 protein].
Shi QF; Wei XL; Li H; Wang BN; Zhang WD; Jiang ZH; Cao K; Li MY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):31-5. PubMed ID: 16495171
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor effects of genetic vaccines against HPV major oncogenes.
Cordeiro MN; Paolini F; Massa S; Curzio G; Illiano E; Duarte Silva AJ; Franconi R; Bissa M; Morghen Cde G; de Freitas AC; Venuti A
Hum Vaccin Immunother; 2015; 11(1):45-52. PubMed ID: 25483514
[TBL] [Abstract][Full Text] [Related]
26. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.
Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K
Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170
[TBL] [Abstract][Full Text] [Related]
27. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
29. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion.
Hu L; Ceresa BP
Virology; 2009 Oct; 393(1):135-43. PubMed ID: 19712955
[TBL] [Abstract][Full Text] [Related]
31. The HPV transcriptome in HPV16 positive cell lines.
Schmitt M; Pawlita M
Mol Cell Probes; 2011; 25(2-3):108-13. PubMed ID: 21439369
[TBL] [Abstract][Full Text] [Related]
32. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events.
Xu J; Fang Y; Qin J; Chen X; Liang X; Xie X; Lu W
FEBS Lett; 2016 Dec; 590(24):4594-4605. PubMed ID: 27859058
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.
Scott ML; Coleman DT; Kelly KC; Carroll JL; Woodby B; Songock WK; Cardelli JA; Bodily JM
Virology; 2018 Jun; 519():1-11. PubMed ID: 29609071
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the Human Papillomavirus 16 E8 Promoter.
Straub E; Fertey J; Dreer M; Iftner T; Stubenrauch F
J Virol; 2015 Jul; 89(14):7304-13. PubMed ID: 25948744
[TBL] [Abstract][Full Text] [Related]
35. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
[TBL] [Abstract][Full Text] [Related]
36. Three spliced mRNAs of TT virus transcribed from a plasmid containing the entire genome in COS1 cells.
Kamahora T; Hino S; Miyata H
J Virol; 2000 Nov; 74(21):9980-6. PubMed ID: 11024126
[TBL] [Abstract][Full Text] [Related]
37. HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7.
Liao S; Deng D; Hu X; Wang W; Li L; Li W; Zhou J; Xu G; Meng L; Wang S; Ma D
Int J Mol Med; 2013 Jan; 31(1):120-8. PubMed ID: 23128250
[TBL] [Abstract][Full Text] [Related]
38. HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.
Ranieri D; Belleudi F; Magenta A; Torrisi MR
Int J Cancer; 2015 Jul; 137(1):61-72. PubMed ID: 25450802
[TBL] [Abstract][Full Text] [Related]
39. Individual and Complementary Effects of Human Papillomavirus Oncogenes on Epithelial Cell Proliferation and Differentiation.
Bergner S; Halec G; Schmitt M; Aubin F; Alonso A; Auvinen E
Cells Tissues Organs; 2016; 201(2):97-108. PubMed ID: 26636751
[TBL] [Abstract][Full Text] [Related]
40. mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: consequences of expression of HPV16 E4 and E5.
Bryant D; Onions T; Raybould R; Flynn Á; Tristram A; Meyrick S; Giles P; Ashelford K; Hibbitts S; Fiander A; Powell N
J Med Virol; 2014 Sep; 86(9):1534-41. PubMed ID: 24898764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
